Related Experiment Video

Updated: Jun 15, 2025

The Transition to an Anterior-Based Muscle Sparing Approach Improves Early Postoperative Function but is Associated with a Learning Curve
09:51

The Transition to an Anterior-Based Muscle Sparing Approach Improves Early Postoperative Function but is Associated with a Learning Curve

Published on: September 7, 2022

2.6K

Equivalent Survivorship of Total Hip Arthroplasty in Patients Who Have Inflammatory Bowel Disease

Benjamin C Schaffler1, Matthew T Kingery1, Akram A Habibi1

  • 1Department of Orthopedic Surgery, NYU Langone Orthopedic Hospital, NYU Langone Health, New York, New York.

The Journal of Arthroplasty
|August 23, 2024
PubMed

Insights

Inflammatory bowel disease (IBD) patients undergoing total hip arthroplasty (THA) experienced more readmissions and ER visits, particularly those with ulcerative colitis (UC). However, IBD did not increase the risk of THA revision or infection.

Area of Science:

  • Orthopaedic surgery
  • Gastroenterology
  • Public health

Background:

  • Inflammatory bowel disease (IBD) is linked to bone density loss and fracture risk.
  • The effect of IBD on total hip arthroplasty (THA) outcomes is not well-established.
  • Crohn's disease (CD) and ulcerative colitis (UC) are major forms of IBD.

Purpose of the Study:

  • To assess if IBD patients face a higher risk of THA failure.
  • To compare THA outcomes between IBD patients and those without IBD.

Main Methods:

  • Utilized the Statewide Planning and Research Cooperative System (2010-2020).
  • Compared 1,165 IBD patients (501 CD, 664 UC) with 117,929 non-IBD patients.
  • Analyzed postoperative outcomes including length of stay, readmission rates, ER visits, and revision rates.

Main Results:

  • CD patients had longer hospital stays and higher 90-day and 1-year readmission rates compared to UC and control groups.
  • IBD patients, especially those with UC, had more 90-day emergency room visits.
  • No significant differences were found in all-cause revision or periprosthetic joint infection rates.

Conclusions:

  • Ulcerative colitis patients experienced increased emergency room visits and hospital readmissions post-THA.
  • Despite higher readmission rates, IBD does not elevate the risk of THA revision or periprosthetic joint infection.
  • THA can be a safe procedure for IBD patients regarding long-term implant survival.
Abstract

Keywords:
complicationsinflammatory bowel diseasepatient outcomesperiprosthetic joint infectiontotal hip arthroplasty

More Related Videos

Individualized Stem-positioning in Calcar-guided Short-stem Total Hip Arthroplasty09:31

Individualized Stem-positioning in Calcar-guided Short-stem Total Hip Arthroplasty

Published on: February 27, 2018

11.7K
Author Spotlight: A Novel 3D-Printed Titanium Implant for Minimally Invasive Treatment of Hip Dysplasia in Young Dogs08:40

Author Spotlight: A Novel 3D-Printed Titanium Implant for Minimally Invasive Treatment of Hip Dysplasia in Young Dogs

Published on: April 19, 2024

2.0K

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
133
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
329
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
205
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
98
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145